P
Pier L. Meroni
Researcher at University of Milan
Publications - 18
Citations - 499
Pier L. Meroni is an academic researcher from University of Milan. The author has contributed to research in topics: Antiphospholipid syndrome & Beta 2-Glycoprotein I. The author has an hindex of 7, co-authored 18 publications receiving 479 citations.
Papers
More filters
Journal ArticleDOI
Statins prevent endothelial cell activation induced by antiphospholipid (anti–β2-glycoprotein I) antibodies: Effect on the proadhesive and proinflammatory phenotype
Pier L. Meroni,Elena Raschi,Cinzia Testoni,Angela Tincani,Genesio Balestrieri,Raffaella Molteni,Munther A. Khamashta,Elena Tremoli,Marina Camera +8 more
TL;DR: Endothelial activation mediated by anti-beta2GPI antibody can be inhibited by statins, and this data provide a rationale for using statins as an additional therapeutic tool in APS.
Journal ArticleDOI
Inflammation and Accelerated Atherosclerosis: Basic Mechanisms
TL;DR: The studies described support a role for immunologic-inflammatory mechanisms in the pathogenesis of atherosclerosis, which is evident in many autoimmune diseases, but also in the general population lacking an overt autoimmune disease.
Journal ArticleDOI
Effect of Additional Treatments Combined with Conventional Therapies in Pregnant Patients with High-Risk Antiphospholipid Syndrome: A Multicentre Study
Amelia Ruffatti,Marta Tonello,Ariela Hoxha,Savino Sciascia,Maria José Cuadrado,José Omar Latino,Sebastián Udry,Tatiana Reshetnyak,N. Costedoat-Chalumeau,N. Costedoat-Chalumeau,Nathalie Morel,Luca Marozio,Angela Tincani,Laura Andreoli,Ewa Haladyj,Pier L. Meroni,Maria Gerosa,Jaume Alijotas-Reig,Sara Tenti,Karoline Mayer-Pickel,Michal J. Simchen,Maria Tiziana Bertero,Sara De Carolis,Véronique Ramoni,Arsène Mekinian,Elvira Grandone,Aldo Maina,Fátima Serrano,Vittorio Pengo,Munther A. Khamashta,Munther A. Khamashta,Munther A. Khamashta +31 more
TL;DR: In this paper, the effect of additional treatments combined with conventional therapy on pregnancy outcomes was examined in high-risk primary antiphospholipid syndrome (PAPS) patients to identify the most effective treatment strategy.
Journal ArticleDOI
Antibodies to endothelial cells identify myocardial damage and predict development of coronary artery disease in patients with transplanted hearts.
W. Page Faulk,Marlene L. Rose,Pier L. Meroni,Nicoletta Del Papa,Ronald J. Torry,Carlos A. Labarrere,Karen Busing,Samantha J Crisp,Michael J. Dunn,David R Nelson +9 more
TL;DR: The significant association of anti-endothelial antibodies with cellular infiltrates, depletion of vascular antithrombin and myocardial damage suggests a role for antibody in the development of transplant-induced arteriopathy.
Additional file 1: Table S1. of Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers
Dirk Roggenbuck,Maria Orietta Borghi,Valentina Somma,Thomas BĂźttner,Peter Schierack,Katja Hanack,Claudia Grossi,Caterina Bodio,Paolo Macor,Philipp von Landenberg,Francesco Boccellato,Michael Mahler,Pier L. Meroni +12 more